LEVOCETIRIZIN DR.MAX

5MG TBL FLM 14

SÚKL code 0202931
Name of the product LEVOCETIRIZIN DR.MAX
_MA_MEDICATION_DETAIL_INFO_MED_NAME i LEVOCETIRIZIN DR.MAX
Supplement 5MG TBL FLM 14
Strenght 5MG
Pharmaceutical form Film-coated tablet
Package 14
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status OTC medicinal products
Active substance LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINI DIHYDROCHLORIDUM)
ATC group R06AE09
ATC group name LEVOCETIRIZIN

Marketing authorisation information

Registration Number 24/ 221/13-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 03. 2019
MA Holder Dr. Max Pharma Ltd., London
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Dr. Max Pharma s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list